You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

BLENOXANE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Blenoxane, and when can generic versions of Blenoxane launch?

Blenoxane is a drug marketed by Bristol Myers Squibb and is included in one NDA.

The generic ingredient in BLENOXANE is bleomycin sulfate. There are six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the bleomycin sulfate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Blenoxane

A generic version of BLENOXANE was approved as bleomycin sulfate by HOSPIRA on March 10th, 2000.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for BLENOXANE?
  • What are the global sales for BLENOXANE?
  • What is Average Wholesale Price for BLENOXANE?
Summary for BLENOXANE
Drug patent expirations by year for BLENOXANE
Recent Clinical Trials for BLENOXANE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
The EMMES CorporationPhase 1
University of California, Los AngelesPhase 1
The Emmes Company, LLCPhase 1

See all BLENOXANE clinical trials

US Patents and Regulatory Information for BLENOXANE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb BLENOXANE bleomycin sulfate INJECTABLE;INJECTION 050443-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bristol Myers Squibb BLENOXANE bleomycin sulfate INJECTABLE;INJECTION 050443-002 Sep 7, 1995 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.